IOM Report Urges Better Care and Support for Dying Children

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 9
Volume 11
Issue 9

WASHINGTON-Dying children and their families often fail to get consistent care and effective help to meet spiritual, physical, and emotional needs, according to a new report from the Institute of Medicine. In funding research on dying children and their families, the report concluded, the National Institutes of Health should begin priority studies to improve the treatment of pain and aspects of care affecting families.

WASHINGTON—Dying children and their families often fail to get consistent care and effective help to meet spiritual, physical, and emotional needs, according to a new report from the Institute of Medicine. In funding research on dying children and their families, the report concluded, the National Institutes of Health should begin priority studies to improve the treatment of pain and aspects of care affecting families.

The report was prepared by a 14-member committee chaired by Richard E. Behrman, MD, JD, University of California, San Francisco.

Insurance, the report said, is often a problem. Most elderly patients are covered by Medicare, but about 15% of children have no medical insurance. Many others are covered by a hodgepodge of private and public insurers, which puts added pressure on their families.

Moreover, complex and restrictive health insurance rules can interfere with the continuity of a child’s care. The panel recommended revising Medicaid and private insurance rules that bar providing life-prolonging therapies to patients receiving hospice care.

The report also cited frustration as a major problem for parents coordinating their children’s care. It suggested that hospitals, hospices, and others involved in the caregiving process work together to promote the flow of needed information. Procedures and protocols are also needed to establish accountability of care.

Another problem cited in the report was the lack of trained health care professionals knowledgeable about end-of-life care and techniques for dealing with bereavement. Even fewer professionals are ready to deal with the special needs of dying children and their families. 

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The FDA approval of tarlatamab in SCLC has received much press attention, according to Daniel R. Carrizosa, MD, MS.
These new guidelines aim to alleviate some of the problems caused by patients with peritoneal metastases being diagnosed with the disease in late stages.
A combined cohort composed of patients from the TROPION-Lung01 and TROPION-Lung-05 trials showed a survival advantage with dato-DXd vs docetaxel.
The National ICE-T Conference may inspire future collaboration between community and academic oncologists in the management of different cancers.
4 experts in this video
2 experts are featured in this series.
4 experts in this video
5 experts are featured in this series
Related Content